Literature DB >> 17588142

Association of HLA DQ B1* and HLA DR B1* alleles with goitrous juvenile autoimmune hypothyroidism--a case control study.

P L Rekha1, Vijayalakshmi Valluri, Shilpa S Rakh, Vinod Pantula, M Ishaq.   

Abstract

The present study was designed to analyze the distribution of HLA DQ B1* and DR B1* in patients with goitrous juvenile autoimmune hypothyroidism from Hyderabad, India. Analysis indicated an increase in the frequencies of HLA DQ B1* 03 allele (P < 0.000) and HLA DR B1* 04 (P < 0.05) alleles in this group of patients when compared to the controls, whereas the frequency of DQB1* 05 was found to be decreased in patients' group compared to the controls (p < 0.01). To conclude, we report a positive correlation between DQ B1* 03 and DR B1* 04 and goitrous juvenile autoimmune hypothyroidism, whereas DQB1* 05 is observed to be negatively correlated with this thyroid dysfunction. Since the disease-susceptible HLA class II alleles appear to differ in various ethnic groups for some autoimmune diseases, the observed association from Indian series of patients holds significance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17588142     DOI: 10.1007/s10875-007-9102-2

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  20 in total

1.  The combination of HLA-DR1 and HLA-DR53 protects against MS.

Authors:  M Luomala; I Elovaara; M Ukkonen; T Koivula; T Lehtimäki
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

2.  HLA class II alleles in Japanese patients with inflammatory bowel disease.

Authors:  S Yoshitake; A Kimura; M Okada; T Yao; T Sasazuki
Journal:  Tissue Antigens       Date:  1999-04

3.  HLA class II antigens and DNA restriction fragment length polymorphism in myasthenia gravis in Japan.

Authors:  K Morita; J Moriuchi; H Inoko; K Tsuji; S Arimori
Journal:  Ann Neurol       Date:  1991-02       Impact factor: 10.422

4.  Association of HLA-DR53 and lack of association of DPB1 alleles with Hashimoto's thyroiditis in Japanese.

Authors:  H Onuma; M Ota; A Sugenoya; H Fukushima; H Inoko; F Iida
Journal:  Tissue Antigens       Date:  1993-09

5.  Postpartum autoimmune thyroid disorder associated with HLA-DR4?

Authors:  H H Lervang; O Pyrds; H P Kristensen; B K Jakobsen; A Svejgaard
Journal:  Tissue Antigens       Date:  1984-04

6.  Histocompatibility leucocyte antigens and closely linked immunomodulatory genes in autoimmune thyroid disease.

Authors:  P J Hunt; S E Marshall; A P Weetman; M Bunce; J I Bell; J A Wass; K I Welsh
Journal:  Clin Endocrinol (Oxf)       Date:  2001-10       Impact factor: 3.478

7.  HLA class II gene polymorphism contributes little to Hashimoto's thyroiditis.

Authors:  D Jenkins; M A Penny; J A Fletcher; K H Jacobs; C H Mijovic; J A Franklyn; M C Sheppard
Journal:  Clin Endocrinol (Oxf)       Date:  1992-08       Impact factor: 3.478

Review 8.  The study of HLA class II and autoimmune diabetes.

Authors:  F Susan Wong; Li Wen
Journal:  Curr Mol Med       Date:  2003-02       Impact factor: 2.222

Review 9.  Molecular analyses of HLA class II-associated susceptibility to subtypes of autoimmune diseases unique to Asians.

Authors:  Y Nishimura; T Kanai; M Oiso; H Tabata; H Ito; J Kira; Y Z Chen; S Matsushita
Journal:  Int J Cardiol       Date:  1998-10-01       Impact factor: 4.164

10.  HLA-DRB1*04 and HLA-DQB1*03 association with the atrophic but not with the goitrous form of chronic autoimmune thyroiditis in a Brazilian population.

Authors:  D Engelbrecht Zantut-Wittmann; L Persoli; M A Tambascia; E Fischer; D Franco Maldonado; A M Costa; E João Pavin
Journal:  Horm Metab Res       Date:  2004-07       Impact factor: 2.936

View more
  1 in total

1.  Selected human leukocyte antigen class II polymorphisms and risk of adult glioma.

Authors:  Bryan A Bassig; Peter D Inskip; Laurie Burdette; William R Shapiro; Robert G Selker; Howard A Fine; Jay S Loeffler; Peter M Black; Robert Dubrow; Alina V Brenner
Journal:  J Neuroimmunol       Date:  2010-12-30       Impact factor: 3.478

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.